Trial Profile
Efficacy and safety of step-down therapy with ciclesonide once-daily and beta2-agonist tulobuterol patch in asthma patients receiving salmeterol/fluticasone propionate diskus: multicenter study.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 18 Jan 2010
Price :
$35
*
At a glance
- Drugs Ciclesonide (Primary) ; Tulobuterol (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 18 Jan 2010 New trial record